NO875286D0 - Fremgangsmaate for replikering av benmarg. - Google Patents

Fremgangsmaate for replikering av benmarg.

Info

Publication number
NO875286D0
NO875286D0 NO1987875286A NO875286A NO875286D0 NO 875286 D0 NO875286 D0 NO 875286D0 NO 1987875286 A NO1987875286 A NO 1987875286A NO 875286 A NO875286 A NO 875286A NO 875286 D0 NO875286 D0 NO 875286D0
Authority
NO
Norway
Prior art keywords
bone marrow
replication
cells
bone
vitro
Prior art date
Application number
NO1987875286A
Other languages
English (en)
Other versions
NO875286L (no
NO179181C (no
NO179181B (no
Inventor
Brian A Naughton
Gail K Naughton
Original Assignee
Marrow Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/036,154 external-priority patent/US4721096A/en
Application filed by Marrow Tech Inc filed Critical Marrow Tech Inc
Publication of NO875286D0 publication Critical patent/NO875286D0/no
Publication of NO875286L publication Critical patent/NO875286L/no
Publication of NO179181B publication Critical patent/NO179181B/no
Publication of NO179181C publication Critical patent/NO179181C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • C12N5/0698—Skin equivalents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60—Materials for use in artificial skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • A61B10/02—Instruments for taking cell samples or for biopsy
    • A61B10/0233—Pointed or sharp biopsy instruments
    • A61B10/025—Pointed or sharp biopsy instruments for taking bone, bone marrow or cartilage samples
    • A61B2010/0258—Marrow samples
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/09—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells
    • C12N2502/094—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells keratinocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1323—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1394—Bone marrow stromal cells; whole marrow
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers
    • C12N2533/40—Polyhydroxyacids, e.g. polymers of glycolic or lactic acid (PGA, PLA, PLGA); Bioresorbable polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Surgery (AREA)
  • Dermatology (AREA)
  • Pathology (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO875286A 1986-04-18 1987-12-17 Tredimensjonal stromacellekultur, anvendelse av stromacellekulturen for dyrking av ulike celletyper in vitro, samt anvendelse av cellekulturen for in vitro testing av cytotoksisk eller medikamentell virkning NO179181C (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US85356986A 1986-04-18 1986-04-18
US07/036,154 US4721096A (en) 1986-04-18 1987-04-03 Process for replicating bone marrow in vitro and using the same
US3811087A 1987-04-14 1987-04-14
PCT/US1987/000869 WO1987006120A1 (en) 1986-04-18 1987-04-15 Process for replicating bone marrow

Publications (4)

Publication Number Publication Date
NO875286D0 true NO875286D0 (no) 1987-12-17
NO875286L NO875286L (no) 1987-12-17
NO179181B NO179181B (no) 1996-05-13
NO179181C NO179181C (no) 1996-08-21

Family

ID=27364979

Family Applications (1)

Application Number Title Priority Date Filing Date
NO875286A NO179181C (no) 1986-04-18 1987-12-17 Tredimensjonal stromacellekultur, anvendelse av stromacellekulturen for dyrking av ulike celletyper in vitro, samt anvendelse av cellekulturen for in vitro testing av cytotoksisk eller medikamentell virkning

Country Status (15)

Country Link
EP (1) EP0309456B1 (no)
JP (2) JP2857392B2 (no)
KR (1) KR0142885B1 (no)
AT (1) ATE127692T1 (no)
AU (3) AU615414B2 (no)
BG (1) BG51337A3 (no)
BR (1) BR8707673A (no)
DE (1) DE3751519T2 (no)
DK (1) DK665687D0 (no)
FI (1) FI100249B (no)
HK (1) HK1007684A1 (no)
HU (1) HU202578B (no)
NO (1) NO179181C (no)
RO (1) RO106655B1 (no)
WO (1) WO1987006120A1 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5902741A (en) * 1986-04-18 1999-05-11 Advanced Tissue Sciences, Inc. Three-dimensional cartilage cultures
AU644578B2 (en) * 1986-04-18 1993-12-16 Marrow-Tech Incorporated Three-dimensional cell and tissue culture system
US5736372A (en) * 1986-11-20 1998-04-07 Massachusetts Institute Of Technology Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure
US5804178A (en) * 1986-11-20 1998-09-08 Massachusetts Institute Of Technology Implantation of cell-matrix structure adjacent mesentery, omentum or peritoneum tissue
US6309635B1 (en) 1986-11-20 2001-10-30 Children's Medical Center Corp. Seeding parenchymal cells into compression resistant porous scaffold after vascularizing in vivo
US5567612A (en) * 1986-11-20 1996-10-22 Massachusetts Institute Of Technology Genitourinary cell-matrix structure for implantation into a human and a method of making
WO1993007913A1 (en) * 1991-10-24 1993-04-29 Children's Medical Center Corporation Neomorphogenesis of urological structures in vivo from cell culture
US5436151A (en) * 1992-04-03 1995-07-25 Regents Of The University Of Minnesota Method for culturing human hematopoietic stem cells in vitro
US5460964A (en) * 1992-04-03 1995-10-24 Regents Of The University Of Minnesota Method for culturing hematopoietic cells
US7214654B1 (en) 1994-12-07 2007-05-08 Karlheinz Schmidt Agent for the manufacture of biological parts including an active ingredient complex and carrying materials suitable for the active ingredient complex
US5709854A (en) * 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US6123727A (en) 1995-05-01 2000-09-26 Massachusetts Institute Of Technology Tissue engineered tendons and ligaments
US5855610A (en) 1995-05-19 1999-01-05 Children's Medical Center Corporation Engineering of strong, pliable tissues
US5728581A (en) * 1995-06-07 1998-03-17 Systemix, Inc. Method of expanding hematopoietic stem cells, reagents and bioreactors for use therein
US5741685A (en) * 1995-06-07 1998-04-21 Children's Medical Center Corporation Parenchymal cells packaged in immunoprotective tissue for implantation
ATE383417T1 (de) * 1998-11-12 2008-01-15 Cytomatrix Llc Produktion lymphoider gewebsspezifischer zellen von hämatopoietischen vorläuferzellen in einem dreidimensionalen system
BR0009403A (pt) * 1999-02-04 2001-11-27 Technion Res & Dev Foundation Método de expansão/conservação das células detronco hemopoiéticas indiferenciadas ou dascélulas progenitoras, método de preparação deum meio condicionado de célula estomacal útil naexpansão/conservação das células de troncohemopoiéticas indiferenciadas ou das célulasprogenitoras, método de transplante de célulasde tronco hemopoiéticas indiferenciadas ou decélulas progenitoras em um recipiente, tampão debiorreator e biorreator
US7087431B2 (en) 2000-03-02 2006-08-08 University Of Rochester Ex vivo generation of functional leukemia cells in a three-dimensional bioreactor
DE10203644A1 (de) * 2002-01-30 2003-08-07 Fraunhofer Ges Forschung Kryokonservierung an textilen Geweben
US8765169B2 (en) 2004-02-13 2014-07-01 Smith & Nephew, Inc. Wound healing profile
KR101318965B1 (ko) * 2005-03-01 2013-10-17 타타 인스티튜트 오브 펀더멘탈 리서치 인공적인 골수-유사 환경을 형성하는 조성물 및 그의 용도
JP4977854B2 (ja) * 2005-10-21 2012-07-18 国立大学法人名古屋大学 組織形成用複合材料およびその製造方法
US20110294215A1 (en) * 2008-10-22 2011-12-01 Regenemed, Inc. Culture systems
AU2012262139B2 (en) * 2011-06-02 2017-02-23 Children's Medical Center Corporation Methods and uses for ex vivo tissue culture systems

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3997396A (en) * 1973-07-02 1976-12-14 Monsanto Company Method for the in vitro propagation and maintenance of cells
US4144126A (en) * 1975-05-21 1979-03-13 Beecham Group Limited Cell culture method
JPS51151384A (en) * 1975-06-20 1976-12-25 Olympus Optical Co Ltd Process for cultivating organic tissue or cells automatically
US4024020A (en) * 1975-12-15 1977-05-17 Monsanto Company Method of cell culture on polyacrylonitrile surface
US4184922A (en) * 1977-11-11 1980-01-22 The Government Of The United States Dual circuit, woven artificial capillary bundle for cell culture
US4228243A (en) * 1978-07-13 1980-10-14 Toray Industries, Inc. Cell culture propagation apparatus
MX163953B (es) * 1984-03-27 1992-07-03 Univ New Jersey Med Procedimiento para preparar una matriz biodegradable a base de colageno

Also Published As

Publication number Publication date
JP3032492B2 (ja) 2000-04-17
DK665687A (da) 1987-12-17
WO1987006120A1 (en) 1987-10-22
FI100249B (fi) 1997-10-31
KR0142885B1 (ko) 1998-07-15
DE3751519T2 (de) 1996-03-28
BR8707673A (pt) 1989-08-15
HUT48112A (en) 1989-05-29
AU7356887A (en) 1987-11-09
JPH10114664A (ja) 1998-05-06
JPH01503195A (ja) 1989-11-02
KR880701093A (ko) 1988-07-25
EP0309456A1 (en) 1989-04-05
EP0309456B1 (en) 1995-09-13
JP2857392B2 (ja) 1999-02-17
HU202578B (en) 1991-03-28
NO875286L (no) 1987-12-17
NO179181C (no) 1996-08-21
AU6815990A (en) 1991-03-14
FI884783L (fi) 1988-10-17
DE3751519D1 (de) 1995-10-19
DK665687D0 (da) 1987-12-17
ATE127692T1 (de) 1995-09-15
NO179181B (no) 1996-05-13
RO106655B1 (ro) 1993-06-30
EP0309456A4 (en) 1989-06-27
BG51337A3 (bg) 1993-04-15
HK1007684A1 (en) 1999-04-23
AU6816090A (en) 1991-03-14
FI884783A0 (fi) 1988-10-17
AU615414B2 (en) 1991-10-03

Similar Documents

Publication Publication Date Title
NO875286D0 (no) Fremgangsmaate for replikering av benmarg.
DK285783A (da) Hjaelpemiddel til indgivning af naeringsstoffer og/eller terapeutiske stoffer til droevtyggere
NL194909B (nl) Werkwijze voor de bereiding van gepolymeriseerd hemoglobine en celvrij vervangingsmiddel voor rode bloedlichaampjes op basis daarvan.
DE3684462D1 (de) Trennverfahren fuer motile saatzellen in vitro, befruchtungsverfahren und durchdringungsmedium fuer saatzellen.
ATE84032T1 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
SE8000435L (sv) N-bensylimidazoler med selektivt inhiberande verkan pa tromboxansyntetasenzymet jemte farmaceutiska beredningar innehallande sadana n-bensylimidazoler och sett for deras framstellning
DE58900183D1 (de) Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung.
DE59307982D1 (de) Verwendung von NADH und NADPH zur Herstellung eines Arzneimittels zur Behandlung von Morbus Alzheimer
NO912621L (no) Fremgangsmaate for innfoering av dna i animalske celler.
WO2003054150A3 (en) Apoptotic ebv-transformed lymphocytes, a therapeutic agent for post-transplant lymphoproliferative disorder
DE69633494D1 (de) Verfahren zur verhinderung von transplantatabstossung
Frodl et al. Effects of hibernation or cryopreservation on the survival and integration of striatal grafts placed in the ibotenate-lesioned rat caudate-putamen
DE69026087D1 (de) Substituierte 2-imidazoline und verfahren zur herstellung sowie deren verwendung
AT375940B (de) Verfahren zur herstellung neuer 10-halogen-14-oxo-15-hydroxy-e-homoeburnane (3 alpha,17 alpha) sowie deren epimeren, optisch aktiven antipoden und physiologisch vertraeglichen saeureadditionssalze
Cumming et al. Permeability of composite chondrocyte-culture-millipore membranes to solutes of varying size and shape
ES2057528T3 (es) Pdgf-a, pdgf-aa, pdgf-ab, procedimientos de preparacion y medicamentos que los contienen.
GR1003185B (el) Μεθοδος για την αντιγραφη του μυελου των οστων.
DK163195C (da) Fremgangsmaade til radioaktiv maerkning af blodceller, oploesning til brug ved fremgangsmaaden, fremgangsmaade til fremstilling af oploesningen, og saet til radioaktiv maerkning af blodceller
IE81126B1 (en) Stromal tissue
BR9809996A (pt) Processo de preparação de embrião de equinos em vista de sua crioconservação
RU93052318A (ru) Способ замещения дефектов головки бедренной кости
Long An examination of the progress of alcohol dependents and their families where the spouse, parent or other relative has attended a relatives' group.
LI et al. Role of hepatic stem cells in hepatic regeneration
DK197091A (da) Fremgangsmaade til fremstilling af proteiner med fviii aktivitet og/eller fviii derivater
SE9003441L (en) Stereo-tactic diagnosis or surgery method - involves three-dimensional location of abnormalities using radiation

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees